Advertisement

Organisation › Details
R-Biopharm AG
R-Biopharm AG is a leading developer of test solutions for clinical diagnostics and food & feed analysis. In both sectors, the R-Biopharm test kits offer high precision and accuracy, key requirements where patient and consumer health is at risk. In clinical diagnostics R-Biopharm possesses many years of sound experience, particularly in the field of infectological stool diagnostics as well as in the field of serological infection diagnostics and allergy diagnostics. 2006 the clinical product portfolio was extended by innovative test systems in the product lines tumor diagnostics and gastroenterology. In the field of food & feed analysis, the company offers a consistently impressive range of approved immunological, enzymatic and microbiological test kits for the detection of residues, food constituents and microbiological contaminants. The company is headquartered in Darmstadt, Germany, and is represented internationally by subsidiaries in the UK, USA, Italy, France, Latin America, Brasil, Spain, Australia and China as well as by a worldwide extensive network of more than 80 distributors. In addition, Switzerland, Austria and the Netherlands are represented by local country managers. *
![]() |
Start | 2001-10-01 existent |
Group | R-Biopharm (Group) | |
Predecessor | R-Biopharm GmbH | |
![]() |
Industry | clinical diagnostics |
Industry 2 | food analysis (food testing) | |
![]() |
Person | Dreher, Ralf (R-Biopharm 201111 CEO) |
Person 2 | Apostel, Frank (R-Biopharm 201311 Director Business Development) | |
![]() |
Region | Darmstadt |
Country | Germany | |
Street | 17 An der neuen Bergstr. | |
City | 64297 Darmstadt | |
Tel | +49-6151-8102-0 | |
Address record changed: 2022-09-20 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2025-03-16 |
Advertisement

More documents for R-Biopharm (Group)
- [1] Robert Bosch GmbH. (4/18/24). "Press Release: Additional Partnership in Medical Technology – Bosch and R-Biopharm to Strengthen Vivalytic Analysis platform". Darmstadt, Gerlingen & Waiblingen....
- [2] Leon-Nanodrugs GmbH. (7/18/23). "Press Release: Leon-Nanodrugs Appoints Dr. Hans Frickel as Chief Executive Officer". Munich....
- [3] R-Biopharm AG. (7/1/19). "Press Release: Distribution of the New Innovative Molecular Diagnostics Platform Vivalytic Starts". Darmstadt....
- [4] Progen Biotechnik GmbH. (5/15/19). "Press Release: Progen Biotechnik GmbH Now With New Joint Leadership". Heidelberg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top